Treating Obesity in Psychiatric Practice: This is Our Fight Too

Friday, September 8, 2023

3:45 PM – 5:00 PM CT

Location: Davidson B

Speaker(s)

Craig Chepke, MD, DFAPA

Medical Director, Excel Psychiatric Associates; Adjunct Associate Professor of Psychiatry, Atrium Health
Excel Psychiatric Associates
Jonathan Meyer, MD

Voluntary Clinical Professor of Psychiatry
University of California, San Diego
University of California, San Diego

The goal of this session is to explore the role of psychiatric clinicians in chronic weight management. We will review the Anti-Obesity Medication (AOM) landscape and evidence-based guideline recommendations for incorporating AOMs as part of a comprehensive care plan, including lifestyle modifications. Real-world case studies of AOM use in psychiatric practice will be discussed. We will also review the proposed mechanism of action and clinical trial data for semaglutide, a GLP-1 receptor agonist approved to treat obesity in adults and adolescents as well as tirzepatide, a dual GLP-1 and GIP receptor agonist being investigated for treatment of obesity in adults.

Learning Objectives:

Identify patients for whom treatment with Anti-Obesity Medications (AOMs) is appropriate
Apply clinical guidelines to individualize the selection of AOMs for specific patient types
Illustrate the proposed mechanism of action of GLP-1 receptor agonists in the treatment of obesity